IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536204. A total of 17 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $254,000 | -52.6% | 1,211,604 | -42.3% | 0.00% | – |
Q2 2018 | $536,000 | +109.4% | 2,100,508 | +105.5% | 0.00% | – |
Q1 2018 | $256,000 | +36.9% | 1,022,104 | +73.1% | 0.00% | – |
Q4 2017 | $187,000 | -26.4% | 590,604 | -13.2% | 0.00% | – |
Q3 2017 | $254,000 | +126.8% | 680,404 | +417.0% | 0.00% | – |
Q2 2017 | $112,000 | -69.8% | 131,604 | +12.7% | 0.00% | -100.0% |
Q1 2017 | $371,000 | +85.5% | 116,804 | +19.7% | 0.00% | – |
Q4 2016 | $200,000 | – | 97,604 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WEDBUSH SECURITIES INC | 276,530 | $5,000 | 0.00% |
IFP Advisors, Inc | 95 | $0 | 0.00% |
Certified Advisory Corp | 20 | $0 | 0.00% |